uce
ProgressImage ProgressImage
Bliss GVS Pharma Ltd
Pharmaceuticals - Indian - Formulations
BSE Code 506197 border-img ISIN Demat INE416D01022 border-img Book Value 93.38 border-img NSE Symbol BLISSGVS border-img Div & Yield % 0.41 border-img Market Cap ( Cr.) 1283.51 border-img P/E 18.8 border-img EPS 6.52 border-img Face Value 1
Quarters
ParticularsDec 2023
()
Sep 2023
()
Jun 2023
()
Gross Sales161.33171.32108.99
Other Operating Income0.000.000.00
Other Income 7.9010.616.53
Total Income169.23181.93115.52
Total Expenditure 132.67129.0197.94
PBIDT36.5652.9217.58
Interest 1.791.181.31
PBDT34.7751.7416.27
Depreciation6.255.685.36
Tax6.4212.052.71
Fringe Benefit Tax0.000.000.00
Deferred Tax1.380.130.70
Reported Profit After Tax20.7233.897.50
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item20.7233.897.50
    
EPS (Unit Curr.)1.993.250.72
EPS (Adj) (Unit Curr.)1.993.250.72
Calculated EPS (Unit Curr.)1.983.250.72
Calculated EPS (Adj) (Unit Curr.)1.983.250.72
Calculated EPS (Ann.) (Unit Curr.)7.9212.982.88
Calculated EPS (Adj) (Ann.) (Unit Curr.)7.9212.982.88
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity10.4710.4410.42
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)22.6630.8916.13
PBDTM(%)21.5530.2014.93
PATM(%)12.8419.786.88
x
x
×
Let's Chat
close
refresh